On the criteria of metabolic syndrome in predicting incident coronary disease and diabetes in Turkish adults/Abdominal obesity and cardiometabolic risk

References (6)

1. Temizhan A. Abdominal obesity and cardiometabolic risk. Anadolu Kardiyol Derg 2007; 7: 35-6
2. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007; 191: 182-90
3. Onat A, Sarı İ, Yazıcı M, Can G, Hergenç G, Avcı GŞ. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome. Int J Cardiol 2006; 108: 89-95
4. Onat A, Can G, Hergenç G, Yazıcı M, Karabulut A, Albayrak S. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension, diabetes, independent of markers of central obesity and inflammation. Int J Obes 2007 Feb 13; [Epub ahead of print]
5. Onat A, Sarı İ, Hergenç G, Yazıcı M, Can G, Uyarel H, et al. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study. Metabolism 2007; 56: 348-56
6. Onat A, Hergenç G, Türkmen S, Yazıcı M, Sarı İ, Can G. Discordance between Insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation. Metabolism 2006; 55: 445-52.